Image via Endpoints News
Enliven Therapeutics: Capital Raising
Enliven Therapeutics (Burlingame, CA-based biotech) priced a $400 million offering on Thursday.
Source: Endpoints News
The leadership read
Capital raise signals growth phase staffing: clinical trial management, regulatory affairs, commercial operations, manufacturing/supply chain, investor relations, and finance teams. May also require CMO/Chief Medical Officer if not already in place for clinical advancement.
Market context: the MitchelLake Talent Market Index reads 108.5 — Hot (+10.8 vs prior month); Americas signal share is easing (-9.8pts).
MitchelLake in this thematic
Our work · 2024
Head of Global Revenue Operations
Hero Inc. Limited
EMEA · revenue operations · saas
Our work · 2017
Retained Search
TNS Mobile Oy
EMEA · Professional Services · market research · mobile analytics
Our work · 2016
Experience Design Market Research Project
Isobar
Oceania · Professional Services · digital agency · experience design